Method for treatment of depression using synaptic pathway training

A method of treating a patient having a neurologic condition by synaptic pathway training comprising steps:

• altering synaptic pathways within an area of the patient's brain with a pharmacologic agent hallucinogenic administered intravenously in a dosage of at least 0.5 mg per kilogram of the patient's weight adjusted to a greater dosage amount as needed based on the patient to obtain a temporary dissociative effect, wherein the hallucinogenic pharmacologic agent is selected based on its effectiveness in increasing hippocampal volume, synaptic pathways, and synaptic density in the hippocampus, wherein altering synaptic pathways comprises increasing hippocampal volume, increasing and activating synaptic pathways, and increasing synaptic density within a hippocampus of the patient's brain;
• stimulating the altered synaptic pathways with cognitive stimulation exercises, wherein the cognitive stimulation exercises are selected based on their efficacy in maintaining the increased hippocampal volume, synaptic pathways, and synaptic density and wherein the cognitive stimulation exercises are initiated within 48 hours after administering the pharmacologic agent;
• and
• extending a treatment result by repeatedly stimulating the altered synaptic pathway with a daily cognitive exercise, selected from the cognitive stimulation exercises, for a minimum of thirty minutes, wherein the daily cognitive exercise comprises engagement with software based cognitive programs designed to increase attention, memory, problem solving, and focus to maintain the increased hippocampal volume, increased synaptic pathways, and increased synaptic density within a hippocampus.